4D Molecular Therapeutics, Inc.
FDMT
$14.34
-$0.30-2.02%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 361.33M | 390.89M | 402.66M | 305.06M | 293.23M |
| Total Receivables | 4.61M | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 17.01M | 14.47M | 10.48M | 7.31M | 10.06M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 382.96M | 405.36M | 413.13M | 312.38M | 303.29M |
|
|
|||||
| Total Current Assets | 382.96M | 405.36M | 413.13M | 312.38M | 303.29M |
| Net Property, Plant & Equipment | 28.93M | 30.94M | 33.01M | 35.06M | 37.15M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 11.44M | 9.86M | 9.19M | 9.38M | 9.39M |
| Total Assets | 492.62M | 512.91M | 566.71M | 423.98M | 473.64M |
|
|
|||||
| Total Accounts Payable | 12.52M | 14.69M | 11.16M | 6.86M | 8.70M |
| Total Accrued Expenses | 25.43M | 22.87M | 26.87M | 24.19M | 19.19M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 5.37M | 5.49M | 5.59M | 5.70M | 5.72M |
| Total Finance Division Other Current Liabilities | 4.35M | 360.00K | 360.00K | 360.00K | 1.07M |
| Total Other Current Liabilities | 4.35M | 360.00K | 360.00K | 360.00K | 1.07M |
| Total Current Liabilities | 47.67M | 43.40M | 43.99M | 37.11M | 34.68M |
|
|
|||||
| Total Current Liabilities | 47.67M | 43.40M | 43.99M | 37.11M | 34.68M |
| Long-Term Debt | 19.59M | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 14.26M | 15.05M | 15.82M | 16.57M | 17.36M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 3.44M | 2.62M | 1.24M | 1.32M | 714.00K |
| Total Liabilities | 84.96M | 61.07M | 61.05M | 55.00M | 52.75M |
|
|
|||||
| Common Stock & APIC | 1.27B | 1.24B | 1.22B | 1.10B | 1.10B |
| Retained Earnings | -858.00M | -785.06M | -716.30M | -735.70M | -678.83M |
| Treasury Stock & Other | -446.00K | -180.00K | 727.00K | 671.00K | 337.00K |
| Total Common Equity | 407.66M | 451.84M | 505.66M | 368.98M | 420.89M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 407.66M | 451.84M | 505.66M | 368.98M | 420.89M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 407.66M | 451.84M | 505.66M | 368.98M | 420.89M |
|
|
|||||